🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Response and Content Elimination

Based on TikTok, the platform has taken down violative content and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.

After minutes of entering one group, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these groups, posts show dark colored parcels with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant health risks”.